SHE:002907

2 stories mentioning SHE:002907Updated 46d ago

Every FINWIRES story that references SHE:002907, newest first.

Pharscin Pharmaceutical Secures China Regulatory Renewal for Acute Pancreatitis API

Chongqing Pharscin Pharmaceutical (SHE:002907) obtained the re-registration from China's drug regulator for its gabexate mesylate active pharmaceutical ingredient.The API is used in the manufacture of gabexate mesylate, an emergency medication for acute pancreatitis, according to a Wednesday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 1% lower Wednesday.

SHE:002907

Asia54d ago

Pharscin Pharmaceutical's Throat Drug Completes Manufacturing Filing Process

Pharscin Pharmaceutical's (SHE:002907) Ganjie Bingmei Tablets completed the domestic drug manufacturing filing process with China's National Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.The drug is used to treat dry throat, sore throat, hoarseness and pharyngeal mucosal congestion.The Chinese pharmaceutical company's shares slipped 1% at the close.

SHE:002907

Track with the FINWIRES app suite

FolioX

Track SHE:002907 in your portfolio

WheelAI

Analyze SHE:002907 options with the wheel strategy

StockInsider

See market sentiment on SHE:002907